Medical regimens for abortion at 12 weeks and above: a systematic review and meta-analysis

Medical regimens for abortion at 12 weeks and above: a systematic review and meta-analysis

Background: Mifepristone and misoprostol are recommended for second-trimester medical abortion, but consensus is unclear on the ideal regimen. Objectives: The objectives were to systematically review randomized controlled trials (RCTs) investigating efficacy, safety and satisfaction of medical abort...

Full description

Bibliographic Details
Main Authors:	Katherine Whitehouse, Ashley Brant, Marita Sporstol Fonhus, Antonella Lavelanet, Bela Ganatra
Format:	Article
Language:	English
Published:	Elsevier 2020-01-01
Series:	Contraception: X
Subjects:	Medical abortion Mifepristone Misoprostol Second trimester
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590151620300204

Similar Items

Comparison of Two Different Intervals of Misoprostol Administration in Second Trimester Abortions
by: Anjali Gupta, et al.
Published: (2023-06-01)

Different Time Schedules of Mifepristone and Misoprostol in Second Trimester Medical Abortion: A Comparative Study
by: Nalini Sharma, et al.
Published: (2017-07-01)

Combined vesicouterine rupture during second-trimester medical abortion for fetal abnormality after prior cesarean delivery: A case report
by: Giuseppe Caruso, et al.
Published: (2021-10-01)

Medical termination for pregnancy in early first trimester (≤ 63 days) using combination of mifepristone and misoprostol or misoprostol alone: a systematic review
by: Ferid A. Abubeker, et al.
Published: (2020-07-01)

Comparison of Two Dosing Regimens of Intravaginal Misoporostol for Second-trimester Abortion
by: Marzieh Ghasemi, et al.
Published: (2018-06-01)

Availability of medical abortion medicines in eight countries: a descriptive analysis of key findings and opportunities
by: Amy Grossman, et al.
Published: (2023-04-01)

Mifepristone and Misoprostol Induced Abortion with A Large Myomatous Uterus
by: Yiu-Tai Li, et al.
Published: (2005-06-01)

Comparison of sequential vaginal and sublingual misoprostol after a vaginal loading dose for second-trimester abortion
by: Ming-Chao Huang, et al.
Published: (2017-06-01)

Concurrent Use of Mifepristone and Misoprostol for Early Medical Abortion
by: Yiu-Tai Li, et al.
Published: (2006-12-01)

Use of Mifepristone and Sublingual Misoprostol for Early Medical Abortion
by: Mau Lin, et al.
Published: (2006-12-01)

Comparison of mifepristone plus misoprostol with misoprostol alone for first trimester medical abortion: A systematic review and meta-analysis
by: Tariku Shimels, et al.
Published: (2023-03-01)

Comparison of the Efficacy of Vaginal Misoprostol with and without Laminaria in Second Trimester Induction Abortion
by: Z Salari, et al.
Published: (2012-02-01)

Comparison of Vaginal Misoprostol, Combined Letrozole and Misoprostol and Combined Laminaria and Misoprostol in the Preparation of Second-Trimester Cervical Abortion
by: Faiba Kahnamooi, et al.
Published: (2018-01-01)

Medical abortion in India – An imperative need for task sharing
by: Nalini Arora, et al.
Published: (2022-01-01)

Short‐term efficacy and safety of early medical abortion in Japan: A multicenter prospective study
by: Yutaka Osuga, et al.
Published: (2023-01-01)

Monitoring Medical Abortion Using Mifepristone/Misoprostol Combination with Ultrasonogram and Serum Human Chorionic Gonadotropin
by: Szu-Yuan Chou, et al.
Published: (2006-03-01)

ALTERNATIVE APPROACHES TO MEDICAL ABORTION
by: K. Telbiyska, et al.
Published: (2024-03-01)

Comparative study of sublingual versus vaginal misoprostol following mifepristone in early first trimester medical termination of pregnancy - a prospective study
by: B. L Pathak, et al.
Published: (2019-01-01)

Efficacy of Mifepristone/Misoprostol Combination for Medical Abortion Determined by Detection of Retained Products in a Community Hospital in Taipei, Taiwan
by: Szu-Yuan Chou, et al.
Published: (2004-06-01)

Outpatient medical management of later second trimester abortion (18–23.6 weeks) with procedural evacuation backup: A large case series
by: Sruthi Chandrasekaran, et al.
Published: (2024-01-01)

Self-managed medication abortion outcomes: results from a prospective pilot study
by: Heidi Moseson, et al.
Published: (2020-10-01)

A prospective study of sublingual misoprostol following mifepristone for second trimester termination of pregnancy
by: Ruchi Gupta, et al.
Published: (2019-07-01)

Trends in medication abortion and the role of low-volume and nonmetropolitan mifepristone purchasers: 2008–2011 and 2014–2017
by: Rachel K. Jones
Published: (2020-01-01)

In-country availability of medical abortion medicines: a description of the framework and methodology of the WHO landscape assessments
by: Ulrika Rehnström Loi, et al.
Published: (2023-01-01)

A prospective study on the effectiveness of a combination regime (Mifepristone and Misoprostol) in comparison with Misoprostol for missed abortion
by: Nidhi Gupta, et al.
Published: (2023-01-01)

Comparing telemedicine to in-clinic medication abortions induced with mifepristone and misoprostol
by: Ellen R Wiebe, et al.
Published: (2020-01-01)

A descriptive analysis of medical abortion commodity availability and pricing at retail outlets in 44 countries across four regions globally
by: Jill Durocher, et al.
Published: (2021-01-01)

Evaluating women’s acceptability of treatment of incomplete second trimester abortion using misoprostol provided by midwives compared with physicians: a mixed methods study
by: Susan Atuhairwe, et al.
Published: (2022-11-01)

Evaluating the safety, effectiveness and acceptability of treatment of incomplete second-trimester abortion using misoprostol provided by midwives compared with physicians: study protocol for a randomized controlled equivalence trial
by: Susan Atuhairwe, et al.
Published: (2019-06-01)

Social inequalities in utilization of a feminist telehealth abortion service in Brazil: A multilevel analysis
by: Sara Larrea, et al.
Published: (2022-12-01)

Women’s perceptions of and experiences with the use of misoprostol for treatment of incomplete abortion in central Malawi: a mixed methods study
by: Bertha Magreta Chakhame, et al.
Published: (2023-02-01)

The Association Between Self-Managed versus Clinician-Managed Abortion and Self-Reported Abortion Complications: A Cross-Sectional Analysis in India
by: Goemans S, et al.
Published: (2023-09-01)

Comparison of the efficacy of sublingual, oral, and vaginal administration of misoprostol in the medical treatment of missed abortion during first trimester of pregnancy: A randomized clinical trial study
by: Behnaz Souizi, et al.
Published: (2020-01-01)

SECOND TRIMESTER MEDICAL TERMINATION OF PREGNANCY. CHALLENGES OF IMPLEMENTATION
by: S. V. Apresyan, et al.
Published: (2017-12-01)

Induction of abortion in the first trimester of pregnancy using letrozole and misoprostol combination versus misoprostol alone - A comparative observational study
by: Swarnali Biswas, et al.
Published: (2024-01-01)

Comparison of the Effect of Letrozole and Misoprostol versus Misoprostol Alone on First Trimester Abortion
by: M Mokhtari, et al.
Published: (2023-03-01)

Comment on “Is It Safe to Provide Abortion Pills Over The Counter? A Study on Outcome Following Self-Medication with Abortion Pills”
by: Laura J. Frye, et al.
Published: (2015-08-01)

Abortion Services Utilization at KAHS during COVID-19 Lockdown
by: Rajiv Shah, et al.
Published: (2020-11-01)

A PROSPECTIVE RANDOMEZED CONTROLLED TRIAL OF TWO REGIMENS OF VAGINAL MISOPROSTOL IN SECOND TRIMESTER TERMINATION OF PREGNANCY
by: L. Eslamian, et al.
Published: (2007-09-01)

A PROSPECTIVE RANDOMEZED CONTROLLED TRIAL OF TWO REGIMENS OF VAGINAL MISOPROSTOL IN SECOND TRIMESTER TERMINATION OF PREGNANCY
by: L. Eslamian, et al.
Published: (2007-12-01)